Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis

Journal of Hepatology

Volumn 60, Issue 5, 2014, Pages 955-961

  Rodríguez, Ezequiel ^a,b,c   Elia, Chiara ^a,b,c,f   Solà, Elsa ^a,b,c   Barreto, Rogelio ^a,b,c   Graupera, Isabel ^a,b,c   Andrealli, Alida ^f   Pereira, Gustavo ^a,b,c   Poca, Maria ^b,d   Sánchez, Jordi ^b,e   Guevara, Mónica ^a,b,c   Soriano, Germán ^b,d   Alessandria, Carlo ^f   Fernández, Javier ^a,b,c   Arroyo, Vicente ^a,b,c   Ginès, Pere ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto Reina Sofia de Investigacion Nefrologica IRSIN   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL DE SABADELL   (Spain)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute on chronic liver failure; Cirrhosis; Hepatorenal syndrome; Terlipressin

Indexed keywords

ALBUMINOID; CREATININE; LYPRESSIN; TERLIPRESSIN;

AGED; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; COMPLICATION; FEMALE; HEART RATE; HEPATORENAL SYNDROME; HUMAN; KIDNEY; LIVER FAILURE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SEPSIS; TREATMENT OUTCOME;

AGED; ALBUMINS; BLOOD PRESSURE; CREATININE; FEMALE; HEART RATE; HEPATORENAL SYNDROME; HUMANS; KIDNEY; LIVER FAILURE; LYPRESSIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 84898775440     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.12.032     Document Type: Article

References (34)

1. R. Moreau, and D. Lebrec The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond Hepatology 43 2006 385 394
2. P. Ginès, M. Guevara, V. Arroyo, and J. Rodes Hepatorenal syndrome Lancet 362 2003 1819 1827
3. P. Angeli, and C. Merkel Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis J Hepatol 48 2008 S93 S103
4. P. Ginès, and R.W. Schrier Renal failure in cirrhosis N Engl J Med 361 2009 1279 1290
5. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis J Hepatol 53 2010 397 417
6. R.W. Schrier, M. Niederberger, A. Weigert, and P. Ginès Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis Semin Liver Dis 14 1994 14 22
7. V. Arroyo, J. Fernandez, and P. Ginès Pathogenesis and treatment of hepatorenal syndrome Semin Liver Dis 28 2008 81 95
8. P. Sort, M. Navasa, and V. Arroyo et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
9. F. Salerno, R.J. Navickis, and M.M. Wilkes Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials Clin Gastroenterol Hepatol 11 2013 123 130
10. J. Fernandez, M. Navasa, and R. Planas et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 2007 818 824
11. P. Ginès, and M. Guevara Therapy with vasoconstrictor drugs in cirrhosis: the time has arrived Hepatology 46 2007 1685 1687
12. V. Arroyo, M. Guevara, and P. Ginès Hepatorenal syndrome in cirrhosis: pathogenesis and treatment Gastroenterology 122 2002 1658 1676
13. R. Moreau Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study Gastroenterology 122 2002 923 930
14. M. Martin-Llahi, M.N. Pepin, and M. Guevara et al. Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study Gastroenterology 134 2008 1352 1359
15. A.J. Sanyal, T. Boyer, and G. Garcia-Tsao et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome Gastroenterology 134 2008 1360 1368
16. S. Neri, D. Pulvirenti, and M. Malaguarnera et al. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome Dig Dis Sci 53 2008 830 835
17. F. Fabrizi, V. Dixit, and P. Martin Meta-analysis: terlipressin therapy for the hepatorenal syndrome Aliment Pharmacol Ther 24 2006 935 944
18. L.L. Gluud, K. Christensen, E. Christensen, and A. Krag Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome Hepatology 51 2010 576 584
19. S.V. Sagi, S. Mittal, K.S. Kasturi, and G.K. Sood Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials J Gastroenterol Hepatol 25 2010 880 885
20. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, and S.M. Opal et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Med 39 2013 165 228
21. F. Salerno, A. Gerbes, P. Ginès, F. Wong, and V. Arroyo Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis Gut 56 2007 1310 1318
22. A. Nazar, G.H. Pereira, and M. Guevara et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome Hepatology 51 2010 219 226
23. J. Uriz, P. Ginès, and A. Cardenas et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome J Hepatol 33 2000 43 48
24. R. Barreto, C. Fagundes, and M. Guevara et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis. Natural history, outcome of kidney function and survival Hepatology 2013 10.1002/hep.26687 [In press]
25. C. Fagundes, M.N. Pepin, and M. Guevara et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis J Hepatol 57 2012 267 273
26. J. Fernandez, J. Acevedo, and M. Castro et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study Hepatology 55 2012 1551 1561
27. M. Martin-Llahi, M. Guevara, and A. Torre et al. Prognostic importance of the cause of renal failure in patients with cirrhosis Gastroenterology 140 2011 488 496
28. A. Cardenas, and P. Ginès Management of complications of cirrhosis in patients awaiting liver transplantation J Hepatol 42 2005 S124 S133
29. R. Moreau, R. Jalan, and P. Ginès et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis Gastroenterology 144 2013 1437
30. J.S. Bajaj Defining acute-on-chronic liver failure: will East and West ever meet? Gastroenterology 144 2013 1337 1339
31. R. Jalan, P. Ginès, and J.C. Olson et al. Acute-on chronic liver failure J Hepatol 57 2012 1336 1348
32. P. Ginès Pharmacological management of hepatorenal syndrome: lessons from non-responders J Hepatol 55 2011 268 269
33. T.D. Boyer, A.J. Sanyal, and G. Garcia-Tsao et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics J Hepatol 55 2011 315 321
34. E.C. Verna, R.S. Brown, and E. Farrand et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis Dig Dis Sci 57 2012 2362 2370